hydroxychloroquine and didanosine

hydroxychloroquine has been researched along with didanosine in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (16.67)	18.2507
2000's	3 (50.00)	29.6817
2010's	1 (16.67)	24.3611
2020's	1 (16.67)	2.80

Authors

Authors	Studies
Lombardo, F; Obach, RS; Waters, NJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Aboulhab, J; Karim, F; Paton, NI	1
Aboulhab, J; Paton, NI	1
Audo, I; Joharjy, H; Le-Lez, ML; Pisella, PJ	1

Reviews

1 review(s) available for hydroxychloroquine and didanosine

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

1 trial(s) available for hydroxychloroquine and didanosine

Article	Year
Hydroxychloroquine, hydroxyurea and didanosine as initial therapy for HIV-infected patients with low viral load: safety, efficacy and resistance profile after 144 weeks. HIV medicine, 2005, Volume: 6, Issue:1 Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Drug Resistance, Viral; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Hydroxychloroquine; Hydroxyurea; Male; Mutation; Treatment Outcome; Viral Load	2005

Article

Year

Hydroxychloroquine, hydroxyurea and didanosine as initial therapy for HIV-infected patients with low viral load: safety, efficacy and resistance profile after 144 weeks.

HIV medicine, 2005, Volume: 6, Issue:1

Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Drug Resistance, Viral; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Hydroxychloroquine; Hydroxyurea; Male; Mutation; Treatment Outcome; Viral Load

2005

Other Studies

4 other study(ies) available for hydroxychloroquine and didanosine

Article	Year
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Hydroxychloroquine+ddI+Hydroxyurea antiretroviral trial, AIDS Research Alliance, Los Angeles. AIDS treatment news, 1999, Dec-03, Issue:No 332 Topics: Anti-HIV Agents; Antimalarials; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Hydroxychloroquine; Hydroxyurea; Los Angeles; Nucleic Acid Synthesis Inhibitors; Patient Selection	1999
Hydroxychloroquine, hydroxycarbamide, and didanosine as economic treatment for HIV-1. Lancet (London, England), 2002, May-11, Volume: 359, Issue:9318 Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Drug Therapy, Combination; Enzyme Inhibitors; Female; HIV Infections; HIV-1; Humans; Hydroxychloroquine; Hydroxyurea; Male; Pilot Projects; Treatment Outcome; Viral Load	2002
A Rare Case of Didanosine-Induced Mid-Peripheral Chorioretinal Atrophy Identified Incidentally 11 Years after the Drug Cessation. Medicina (Kaunas, Lithuania), 2022, May-30, Volume: 58, Issue:6 Topics: Adult; Atrophy; Choroid Diseases; Didanosine; Emtricitabine; Female; HIV Infections; Humans; Hydroxychloroquine; Retinal Degeneration; Tenofovir; Tomography, Optical Coherence	2022